Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2022

04-08-2021 | Crohn's Disease | Editorial

No Longer Stretching Credibility: Mechanical Force Meets Inflammation in Experimental Intestinal Stenosis

Authors: Calen A. Steiner, Florian Rieder

Published in: Digestive Diseases and Sciences | Issue 5/2022

Login to get access

Excerpt

The pathophysiology of Crohn’s disease (CD) is rooted in a complex interplay of genetic, immunological, and environmental factors [1]. The heterogeneity of the underlying mechanisms of disease is mirrored by the heterogeneous disease manifestations in different segments of the GI tract. Though intestinal fibrosis leading to stenosis is recognized as a major complication of CD, its mechanisms remain largely elusive [1]. Current concepts of its pathogenesis suggest that intestinal stenosis requires initiation through an inflammatory insult leading to tissue damage, fibrosis, and ultimately stenosis in patients with CD [1]. It has however become apparent that once established, fibrosis can evolve independently of inflammation, as has been shown for extraintestinal fibrosis, as well as for intestinal fibrogenesis [13]. One putative mechanism driving the inflammation-independent progression of fibrosis is the mechanical properties of a given intestinal tissue [3]. The stiffness of the intestine in inflammation is increased compared with unaffected segments [4]; the stiffness of strictured segments is approximately six times higher compared with non-strictured segments. [3] Stiffness of the extracellular matrix (ECM) environment itself is a driver of mesenchymal cell activation to produce more ECM in a forward-feeding loop eventuating in intestinal obstruction. …
Literature
1.
go back to reference Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:340-350.e6.CrossRef Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:340-350.e6.CrossRef
2.
go back to reference Steiner CA, Rodansky ES, Johnson LA, et al. AXL is a potential target for the treatment of intestinal fibrosis. Inflamm Bowel Dis. 2020. Steiner CA, Rodansky ES, Johnson LA, et al. AXL is a potential target for the treatment of intestinal fibrosis. Inflamm Bowel Dis. 2020.
3.
go back to reference Johnson LA, Rodansky ES, Sauder KL, et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis. 2013;19:891-903.CrossRef Johnson LA, Rodansky ES, Sauder KL, et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis. 2013;19:891-903.CrossRef
4.
go back to reference Stewart DC, Berrie D, Li J, et al. Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. PLoS One. 2018;13:e0200377.CrossRef Stewart DC, Berrie D, Li J, et al. Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. PLoS One. 2018;13:e0200377.CrossRef
5.
go back to reference Fazio VW, Tjandra JJ, Lavery IC, et al. Long-term follow-up of strictureplasty in Crohn's disease. Dis Colon Rectum. 1993;36:355-61.CrossRef Fazio VW, Tjandra JJ, Lavery IC, et al. Long-term follow-up of strictureplasty in Crohn's disease. Dis Colon Rectum. 1993;36:355-61.CrossRef
6.
go back to reference Maconi G, Sampietro GM, Cristaldi M, et al. Preoperative characteristics and postoperative behavior of bowel wall on risk of recurrence after conservative surgery in Crohn's disease: a prospective study. Ann Surg. 2001;233:345-52.CrossRef Maconi G, Sampietro GM, Cristaldi M, et al. Preoperative characteristics and postoperative behavior of bowel wall on risk of recurrence after conservative surgery in Crohn's disease: a prospective study. Ann Surg. 2001;233:345-52.CrossRef
8.
go back to reference Georgopoulos I, Mavrigiannaki E, Stasinopoulou S, et al. Experimental models of partial intestinal obstruction in young mice: establishment, and evaluation. J Surg Res. 2020;252:206-215.CrossRef Georgopoulos I, Mavrigiannaki E, Stasinopoulou S, et al. Experimental models of partial intestinal obstruction in young mice: establishment, and evaluation. J Surg Res. 2020;252:206-215.CrossRef
9.
go back to reference Harrison DL, Fang Y, Huang J. T-Cell mechanobiology: force sensation, potentiation, and translation. Front Phys. 2019;7. Harrison DL, Fang Y, Huang J. T-Cell mechanobiology: force sensation, potentiation, and translation. Front Phys. 2019;7.
10.
go back to reference Wipff PJ, Rifkin DB, Meister JJ et al. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007;179:1311-23. Wipff PJ, Rifkin DB, Meister JJ et al. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007;179:1311-23.
Metadata
Title
No Longer Stretching Credibility: Mechanical Force Meets Inflammation in Experimental Intestinal Stenosis
Authors
Calen A. Steiner
Florian Rieder
Publication date
04-08-2021
Publisher
Springer US
Keyword
Crohn's Disease
Published in
Digestive Diseases and Sciences / Issue 5/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07170-4

Other articles of this Issue 5/2022

Digestive Diseases and Sciences 5/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.